Figure 1. Magnetic resonance imaging of the head shows a mass measuring 4.2 cm in diameter with cystic contents and small areas of nodular and rim enhancement. The mass causes marked compression of the cortical mantle throughout the inferior parietal and temporal regions.
Figure 2. Multiple mature germ cell elements are seen within the resected tumor. Mature cartilage can be seen adjacent to respiratory-type epithelium (periodic acid–Schiff, original magnification ×40).
Figure 3. Much of the tumor is composed of primitive neuroectodermal cells. Focally, medulloepitheliomalike differentiation is present, with the tumor cells forming primitive neural tubes (hematoxylin-eosin, original magnification ×40).
Congenital intracranial tumors are rare, accounting for 0.5% to 1.5% of all childhood brain tumors.1 Data from the National Cancer Institute's Surveillance Epidemiology and End Results program suggest that the incidence of these tumors has increased during the past 20 years.2
The most common clinical presentation is macrocrania, hydrocephalus, and a bulging fontanel. Signs of increased intracranial pressure such as papilledema and nuchal rigidity are less frequent because of decompression through the cranial sutures. Other findings include paresis, cranial nerve deficits, convergence nystagmus (Parinaud syndrome), seizures, vomiting, and lethargy. A supratentorial location of the tumor is more common in infants than in older children. Differential diagnosis of supratentorial tumors includes astrocytoma, ependymoma, primitive neuroectodermal tumor, germ cell tumor, and choroid plexus papilloma. In a series studied at University of California–San Francisco, the most common brain tumor presenting or producing symptoms at birth was teratoma, occurring about 5 times more frequently than the second most common type, astrocytoma.3
In general, intracranial teratomas are extremely uncommon. Most are located in the pineal region, but about 20% are located in the suprasellar or infrasellar regions.4 Histologically they are classified as mature, immature, or teratoma with malignant components based on the amount of tissue differentiation. They contain structures derived from all 3 germ cell layers. Immature teratomas may also contain primitive neural tissue.5 They may produce plasma or cerebrospinal fluid markers such as α1-fetoprotein and human chorionic gonadotropic hormone. Prenatal diagnosis has increased with the use of ultrasonography.6
Congenital intracranial teratomas have a poor prognosis. There are several cases reported in the literature of stillborn infants presenting with severe macrocephaly, history of polyhydramnios, and even skull rupture at delivery.7- 9 Most of these infants die within the first few months of life and the longest survival reported has been 1.5 years.6
Treatment includes radical surgical resection of the tumor, followed by either radiotherapy and/or chemotherapy. The extent of surgical resection is an important prognostic factor.4 If the patient survives, radiotherapy is usually postponed until 24 to 36 months of age to avoid complications such as stunted growth, endocrine disturbances, and neuropsychologic problems.
Accepted for publication January 1, 1999.
Reprints: Eneida Rosario, MD, Department of Pediatrics, Rainbow Babies and Children's Hospital, 11100 Euclid Ave, Mailstop 6002, Cleveland, OH 44106.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.